Glycerine (Glycerol): Safe Uses and Overdose Management
Glycerol is safe for topical use in cosmetics and dermatological preparations at any concentration, and for oral use in medical contexts at doses up to 1.5 g/kg body weight in adults, but young children under 8 years should avoid oral glycerol-containing products due to risk of acute intoxication syndrome.
Topical Uses
Glycerol is extensively validated for dermatological applications:
Moisturization and skin barrier support: Glycerol functions as a humectant that improves stratum corneum hydration, enhances epidermal barrier function, and accelerates wound healing 1. The 2023 AAD guidelines support moisturizer use (including glycerol-containing products) for atopic dermatitis management, noting they are generally safe with rare serious adverse effects 2.
Safety profile: A comprehensive 2019 cosmetic safety assessment concluded glycerol is safe as a cosmetic ingredient at all concentrations used in practice 3. Topical application carries minimal risk and improves skin properties in xerotic conditions 1.
Mechanism: Glycerol works through multiple pathways including aquaporin-3 transport channels and demonstrates antimicrobial effects, inhibition of lipid phase transitions, and protection against irritants 1.
Oral/Systemic Uses in Adults
Glycerol has established medical applications when used appropriately:
Therapeutic dosing: The maximum safe oral dose is 1.5 g/kg body weight 4. For intravenous use, doses of 0.25-2.0 g/kg effectively reduce intracranial pressure in various neurological conditions 5.
Clinical applications: Historically used for cerebral edema, glaucoma, intracranial hypertension, and hyperhydration strategies during exercise 6, 5. When administered IV, use 10% glycerol in 5% dextrose with normal saline at rates ≤6 mg/kg/min to minimize hemolysis 5.
Pharmacokinetics: Oral glycerol increases serum osmolality by >10 mOsmol/kg at doses >1.0 g/kg, with serum concentrations reaching ~20 mmol/L 6.
Critical Pediatric Warning
Young children face severe toxicity risk from oral glycerol:
Age restriction: Children under 8 years should avoid slush ice drinks and other glycerol-containing beverages 7. The median age of intoxication cases is 3.5 years (range 2-6.75 years).
Intoxication syndrome: Presents within 60 minutes with decreased consciousness (94%), hypoglycemia (95%), metabolic acidosis (94%), pseudohypertriglyceridemia (89%), and hypokalemia (75%) 7. This mimics inherited metabolic disorders.
Mechanism: Young children have immature glycerol metabolism pathways, making them uniquely vulnerable to acute toxicity even from commercially available products 7.
Overdose Management
For glycerol overdose, immediately apply supportive care targeting metabolic derangements:
Immediate Actions (from FDA labeling for allergenic extracts containing glycerol) 8:
If injection-related: Apply tourniquet above injection site
Epinephrine administration:
- Adults: 0.3-0.5 mL of 1:1000 IM/SC in opposite arm
- Infants to 2 years: 0.05-0.1 mL
- Children 2-6 years: 0.15 mL
- Children 6-12 years: 0.2 mL
- Repeat in 5-10 minutes if necessary
- Loosen tourniquet every 10 minutes
Bronchodilator therapy if unresponsive to epinephrine:
Supportive Care for Oral Overdose:
Based on the case series and kinetic data 4, 7:
- Dextrose administration: Treat hypoglycemia aggressively (present in 95% of pediatric cases)
- Metabolic acidosis correction: Sodium bicarbonate as needed
- Electrolyte replacement: Particularly potassium (hypokalemia in 75%)
- Fluid management: IV fluids, vasopressors, and oxygen for shock/hypotension 8
- Respiratory support: Intubation and mechanical ventilation if consciousness severely impaired
- Monitoring: Serial glucose, electrolytes, lactate, and osmolality measurements
Key Pitfalls:
- Pseudohypertriglyceridemia: Elevated triglycerides (>3,000 mg/dL) in glycerol overdose are artifactual due to assay interference—do not treat as true hypertriglyceridemia 4, 7
- Mimics metabolic disease: Presentation resembles gluconeogenesis disorders; glyceroluria on urine organic acids confirms diagnosis 7
- Rebound phenomenon: With IV use, intermittent rather than continuous dosing prevents rebound cerebral overhydration 5
The evidence demonstrates glycerol's safety profile is concentration and age-dependent, with topical use being universally safe 2, 3, adult oral use safe within dosing limits 6, 5, but pediatric oral exposure requiring strict avoidance 7.